Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Much more than a Nibble
View:
Post by GoldenInvestor on Apr 13, 2022 9:14am

Much more than a Nibble

Sure there are is the promise of loan repayment & interest compounded !

But there is also 1,500,000 warrants AND 

2 POTENTIAL PRV's!

with the benefits of potential company ownership, there is the potential of significant upside in the drug Dev side for Knight & the possible sale of 2 PRV's if they choose to go that route!!

anyone know the VALUE of the sale of ONE of those? with warrants & future shares.., possibilities 

GENIUS
Comment by MrMugsy on Apr 13, 2022 10:20am
Yes - but all those benefits reside with Appili and Goodman (along with the risk) as Samira/GUD is likely focusing on licensing developed drugs.  Goodman is willing to take the risk.  I can only guess that if he ever gets rights to the drugs in those locations, GUD would likely get first opportunity to purchase the rights for Canada, Israel and LATAM from him. Actually ... as of this ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities